The LDT/PPT has been shown to display tau pathology in AD patients, but interestingly, not cholinergic cell loss (Mufson et al., 1988; Dugger et al., 2012; Kotagal et al., 2012). The gene discussed is MAPT; the disease is Alzheimer disease.